File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.mehy.2008.01.003
- Scopus: eid_2-s2.0-45649083848
- PMID: 18280054
- WOS: WOS:000258013800043
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Hippocampus atrophy as the drug target requires rethinking
Title | Hippocampus atrophy as the drug target requires rethinking |
---|---|
Authors | |
Issue Date | 2008 |
Publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy |
Citation | Medical Hypotheses, 2008, v. 71 n. 2, p. 324 How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/161598 |
ISSN | 2023 Impact Factor: 2.1 2023 SCImago Journal Rankings: 0.587 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yuan, T | - |
dc.date.accessioned | 2012-09-03T07:30:08Z | - |
dc.date.available | 2012-09-03T07:30:08Z | - |
dc.date.issued | 2008 | - |
dc.identifier.citation | Medical Hypotheses, 2008, v. 71 n. 2, p. 324 | - |
dc.identifier.issn | 0306-9877 | - |
dc.identifier.uri | http://hdl.handle.net/10722/161598 | - |
dc.language | eng | - |
dc.publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy | - |
dc.relation.ispartof | Medical Hypotheses | - |
dc.rights | NOTICE: this is the author’s version of a work that was accepted for publication in Medical Hypotheses. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Medical Hypotheses, [VOL 71, ISSUE 2, 2008] DOI 10.1016/j.mehy.2008.01.003 | - |
dc.subject.mesh | Atrophy - drug therapy - etiology - prevention and control | - |
dc.subject.mesh | Drug Delivery Systems - methods | - |
dc.subject.mesh | Hippocampus - drug effects - pathology | - |
dc.subject.mesh | Models, Theoretical | - |
dc.subject.mesh | Pharmaceutical Preparations - administration and dosage - classification - metabolism | - |
dc.title | Hippocampus atrophy as the drug target requires rethinking | en_US |
dc.type | Article | en_US |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1016/j.mehy.2008.01.003 | - |
dc.identifier.pmid | 18280054 | - |
dc.identifier.scopus | eid_2-s2.0-45649083848 | - |
dc.identifier.hkuros | 170676 | - |
dc.identifier.volume | 71 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 324 | - |
dc.identifier.epage | 324 | - |
dc.identifier.isi | WOS:000258013800043 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 0306-9877 | - |